Metastatic renal-cell carcinoma: What causes occasional dramatic regressions?

被引：29

作者：

Young, RC ^{[1
]}

机构：

[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1998年 / 338卷 / 18期

关键词：

D O I：

10.1056/NEJM199804303381811

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1305 / 1306

页数：2

共 12 条

[1] RANDOMIZED PHASE-II TRIAL OF HIGH-DOSE INTERLEUKIN-2 EITHER ALONE OR IN COMBINATION WITH INTERFERON-ALFA-2B IN ADVANCED RENAL-CELL CARCINOMA [J].

ATKINS, MB ;

SPARANO, J ;

FISHER, RI ;

WEISS, GR ;

MARGOLIN, KA ;

FINK, KI ;

RUBINSTEIN, L ;

LOUIE, A ;

MIER, JW ;

GUCALP, R ;

SOSMAN, JA ;

BOLDT, DH ;

DOROSHOW, JH ;

ARONSON, FR ;

SZNOL, M .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (04) :661-670

[2] PHASE-II TRIAL OF HIGH-DOSE INTERMITTENT INTERLEUKIN-2 IN METASTATIC RENAL-CELL CARCINOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY [J].

BUKOWSKI, RM ;

GOODMAN, P ;

CRAWFORD, ED ;

SERGI, JS ;

REDMAN, BG ;

WHITEHEAD, RP .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (02) :143-146

[3] EORTC(30885) RANDOMIZED PHASE-III STUDY WITH RECOMBINANT INTERFERON-ALPHA AND RECOMBINANT INTERFERON-ALPHA AND INTERFERON-GAMMA IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA [J].

DEMULDER, PHM ;

OOSTERHOF, GON ;

BOUFFIOUX, C ;

VANOOSTEROM, AT ;

VERMEYLEN, K ;

SYLVESTER, R .

BRITISH JOURNAL OF CANCER, 1995, 71 (02) :371-375

[4] Danger versus tolerance: Paradigms for future studies of tumor-specific cytotoxic T lymphocytes [J].

Fenton, RG ;

Longo, DL .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (04) :272-275

[5] Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma [J].

Gleave, ME ;

Elhilali, M ;

Fradet, Y ;

Davis, I ;

Venner, P ;

Saad, F ;

Klotz, LH ;

Moore, MJ ;

Paton, V ;

Bajamonde, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (18) :1265-1271

[6] Renal-cell carcinoma [J].

Motzer, RJ ;

Bander, NH ;

Nanus, DM .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (12) :865-875

[7]

Motzer Robert J., 1997, P885

[8] Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma [J].

Negrier, S ;

Escudier, B ;

Lasset, C ;

Douillard, JY ;

Savary, J ;

Chevreau, C ;

Ravaud, A ;

Mercatello, A ;

Peny, J ;

Mousseau, M ;

Philip, T ;

Tursz, T .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (18) :1272-1278

[9] UNEXPLAINED SPONTANEOUS REGRESSION AND ALPHA-INTERFERON AS TREATMENT FOR METASTATIC RENAL-CARCINOMA [J].

OLIVER, RTD ;

NETHERSELL, ABW ;

BOTTOMLEY, JM .

BRITISH JOURNAL OF UROLOGY, 1989, 63 (02) :128-131

[10] PATTERNS OF FAILURE FOLLOWING SURGICAL RESECTION OF RENAL-CELL CARCINOMA - IMPLICATIONS FOR ADJUVANT LOCAL AND SYSTEMIC THERAPY [J].

RABINOVITCH, RA ;

ZELEFSKY, MJ ;

GAYNOR, JJ ;

FUKS, Z .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (01) :206-212

← 1 2 →